Search results
Author(s):
Khaled Elenizi
,
Rasha Alharthi
Added:
6 months ago
Author(s):
Paul Foley
,
Honey Thomas
,
Mark Dayer
,
et al
Added:
10 months ago
Added:
3 months ago
Source:
Arrhythmia Academy
AUTHOR: David RamseyLeading cardiovascular societies have unveiled an updated appropriate use criteria (AUC) document redefining clinical decision-making for cardiac implantable devices. The practice guideline entitled "ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing" was published online…
View more
Author(s):
Elaine Wan
,
Majd Al Deen Alhuarrat
Added:
11 months ago
In the latest episode of Arrhythmia Academy's Journal Club, Dr Elaine Wan (Columbia University, New York, NY, US) and Dr Majd Al Deen Alhuarrat (Albert Einstein College of Medicine, New York, NY, US) discuss the in-hospital outcomes and complications of using leadless pacemakers and traditional transvenous pacemakers.Dr Alhuarrat provides a concise history and background of transvenous and…
View more
Author(s):
Valentina Kutyifa
Added:
3 weeks ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of…
View more
Sandrine Venier
Research Area(s) / Expertise:
Author
Author(s):
Angelo Auricchio
,
Anne B Curtis
Added:
1 year ago
Prof Anne Curtis (University of Buffalo, US) and Prof Angelo Auricchio (Fondazione Cardiocentro Ticino, CH) discuss contemporary clinical data of Implantable Cardioverter Defibrillators (ICDs) from real world populations. The discussion is focused on the importance and impact of ICD therapy on prevention of sudden cardiac death by analysing the latest presented data.In context, the data analysed…
View more
Author(s):
Added:
1 month ago
EHRA 2025 - Long-term insights from pacemaker implantation after transcatheter aortic valve implantation (TAVI) show patients receiving pacemaker therapy within 30 days after TAVI had a significantly worse prognosis compared to patients with no pacemaker therapy in regards to all-cause death and CV death at one, five and ten year follow-ups.Prof Patrick Badertscher (University Hospital Basel,…
View more